Inventor
LEADBETTER MICHAEL R
US52 patents
⚠️ This page may combine multiple inventors who share the name “LEADBETTER MICHAEL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE INC
22 patentsUS6670376B1Dec 30, 2003
Aryl aniline β2 adrenergic receptor agonists
THERAVANCE INC129 citations98
US6635618B2Oct 21, 2003
Glycopeptide phosphonate derivatives
THERAVANCE INC69 citations97
US7208471B2Apr 24, 2007
Glycopeptide phosphonate derivatives
THERAVANCE INC24 citations96
US6887976B2May 3, 2005
Glycopeptide phosphonate derivatives
THERAVANCE INC24 citations96
US6872701B2Mar 29, 2005
Glycopeptide phosphonate derivatives
THERAVANCE INC23 citations96
US7351691B2Apr 1, 2008
Glycopeptide phosphonate derivatives
THERAVANCE INC14 citations93
US7008923B2Mar 7, 2006
Glycopeptide phosphonate derivatives
THERAVANCE INC16 citations93
US6620781B2Sep 16, 2003
Glycopeptide carboxy-saccharide derivatives
THERAVANCE INC27 citations93
US6979723B2Dec 27, 2005
Process for preparing glycopeptide phosphonate derivatives
THERAVANCE INC13 citations92
US6518242B1Feb 11, 2003
Derivatives of glycopeptide antibacterial agents
THERAVANCE INC26 citations91
US7074890B2Jul 11, 2006
Process for preparing glycopeptide phosphonate derivatives
THERAVANCE INC11 citations84
US7728104B2Jun 1, 2010
Process for preparing glycopeptide phosphonate derivatives
THERAVANCE INC6 citations74
US7700550B2Apr 20, 2010
Glycopeptide phosphonate derivatives
THERAVANCE INC6 citations74
US7301004B2Nov 27, 2007
Process for preparing glycopeptide phosphonate derivatives
THERAVANCE INC5 citations74
US7265086B2Sep 4, 2007
Glycopeptide carboxy-saccharide derivatives
THERAVANCE INC5 citations74
US7157554B2Jan 2, 2007
Glycopeptide carboxy-saccharide derivatives
THERAVANCE INC8 citations74
US6903070B2Jun 7, 2005
Glycopeptide carboxy-saccharide derivatives
THERAVANCE INC9 citations74
US7405199B2Jul 29, 2008
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC5 citations73
US6962970B2Nov 8, 2005
Glycopeptide derivatives and pharmaceutical compositions containing the same
THERAVANCE INC4 citations73
US8030445B2Oct 4, 2011
Glycopeptide derivative
THERAVANCE INC1 citations63
US7582765B2Sep 1, 2009
Aryl aniline β2 adrenergic receptor agonists
THERAVANCE INC2 citations62
US7553971B2Jun 30, 2009
Aryl aniline β2 adrenergic receptor agonists
THERAVANCE INC1 citations52
ARDELYX INC
8 patentsUS8916569B2Dec 23, 2014
Compounds and methods for inhibiting phosphate transport
ARDELYX INC7 citations83
US8815908B2Aug 26, 2014
Compounds and methods for inhibiting phosphate transport
ARDELYX INC7 citations83
US8815910B2Aug 26, 2014
Compounds and methods for inhibiting phosphate transport
ARDELYX INC7 citations83
US8809339B2Aug 19, 2014
Compounds and methods for inhibiting phosphate transport
ARDELYX INC8 citations83
US9301951B2Apr 5, 2016
Compounds and methods for inhibiting phosphate transport
ARDELYX INC0 citations51
US9289430B2Mar 22, 2016
Compounds and methods for inhibiting phosphate transport
ARDELYX INC0 citations51
US9289429B2Mar 22, 2016
Compounds and methods for inhibiting phosphate transport
ARDELYX INC0 citations51
US9278102B2Mar 8, 2016
Compounds and methods for inhibiting phosphate transport
ARDELYX INC0 citations51
LEADBETTER MICHAEL R
7 patentsUS8101791B2Jan 24, 2012
Aminotetralin compounds as mu opioid receptor antagonists
LEADBETTER MICHAEL R5 citations73
US8101575B2Jan 24, 2012
Glycopeptide phosphonate derivatives
LEADBETTER MICHAEL R5 citations73
US8314128B2Nov 20, 2012
Aminotetralin compounds as mu opioid receptor antagonists
LEADBETTER MICHAEL R4 citations62
US8093354B2Jan 10, 2012
Process for preparing glycopeptide phosphonate derivatives
LEADBETTER MICHAEL R1 citations62
US8859506B2Oct 14, 2014
Glycopeptide phosphonate derivatives
LEADBETTER MICHAEL R0 citations52
US8541375B2Sep 24, 2013
Glycopeptide phosphonate derivatives
LEADBETTER MICHAEL R0 citations52
US8492399B2Jul 23, 2013
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
LEADBETTER MICHAEL R0 citations52
TRAPP SEAN G
5 patentsUS8153686B2Apr 10, 2012
Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
TRAPP SEAN G6 citations83
US8106232B2Jan 31, 2012
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
TRAPP SEAN G5 citations73
US8969370B2Mar 3, 2015
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
TRAPP SEAN G0 citations51
US8952031B2Feb 10, 2015
Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
TRAPP SEAN G0 citations51
US8703791B2Apr 22, 2014
3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
TRAPP SEAN G0 citations51
ADVANCED MEDICINE INC
3 patentsUS6444786B1Sep 3, 2002
Glycopeptide derivatives and pharmaceutical compositions containing the same
ADVANCED MEDICINE INC41 citations95
US6392012B1May 21, 2002
Glycopeptide derivatives and pharmaceutical compositions containing the same
ADVANCED MEDICINE INC70 citations95
US6355810B1Mar 12, 2002
Multibinding inhibitors of HMG-CoA reductase
ADVANCED MEDICINE INC25 citations88
ZENECA LTD
2 patentsICI AMERICA INC
1 patentTRAPP SEAN
1 patentICI PLC
1 patentShowing the top 50 of 52 patents by PatentIndex Score.